Calendar Avenue Therapeutics, Inc.

Equities

ATXI

US05360L3042

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
0.1475 USD -3.34% Intraday chart for Avenue Therapeutics, Inc. -6.82% -8.39%

Chart calendar Avenue Therapeutics, Inc.

f74007161c9ace4392a71a56631f.mx8Ez6MOroN67o23HMdDhxCfNsRcLovRRf49zvqa38s.rSdGt8F9mucdi-XtSJML4mrYXbEXf8-zC4QKp7Tds57cXk-AzGT7thLD6g~fac67ca281e8118640f2438d855d4302

Upcoming events on Avenue Therapeutics, Inc.

2024-04-04 11:00 am Investor Meeting - Key Opinion Leader
2024-05-12 Q1 2024 Earnings Release (Projected)
2024-08-11 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-24 Q4 2024 Earnings Release (Projected)

Past events on Avenue Therapeutics, Inc.

2024-03-18 04:05 pm Q4 2023 Earnings Release
2024-03-13 01:30 pm American Society for Experimental Neurotherapeutics Meeting
2024-01-18 10:00 am Sidoti Micro Cap Investor Conference
2023-12-02 12:00 pm American Epilepsy Society Meeting - Poster Number :444
2023-11-30 American Epilepsy Society Meeting
2023-11-13 04:05 pm Q3 2023 Earnings Release
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-08-10 04:15 pm Q2 2023 Earnings Release
2023-06-22 09:30 am Annual General Meeting
2023-05-12 08:30 am Q1 2023 Earnings Release
2023-05-04 04:00 pm Aegis Capital Virtual Conference
2023-03-30 04:01 pm Q4 2022 Earnings Release
2023-01-30 03:00 pm Annual General Meeting
2022-11-10 04:10 pm Q3 2022 Earnings Release
2022-08-14 Interim 2022 Earnings Release
2022-02-23 02:30 pm Aegis Capital Virtual Summit
2021-12-16 09:00 am Annual General Meeting
2020-10-12 08:30 am IV Tramadol CRL Update Call
2020-08-14 07:30 am Interim 2020 Earnings Release
2020-06-16 10:00 am Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-26,3
-25,5
-2.92%
-5,21
-5,41
3.59%
-8,04
-4,83
-66.49%
-14,5
-10,5
-37.95%

-13,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-25,9
-25,2
-2.76%
-5,15
-5,12
-0.52%
0,00
0,00
-
-10,5
-9,58
-9.54%

-13,3

Net income
Million USD
Released
Forecast
Spread
-25,9
-25,2
-2.76%
-5,15
-5,12
-0.52%
-3,55
-4,83
26.4%
-10,4
-9,37
-10.69%

-13,3

EPS
USD
Released
Forecast
Spread
-24,7
-24,0
-3.13%
-4,65
-4,65
0%
-1,63
-2,12
23.11%
-0,98
-0,98
-0.51%

-0,41

Announcement Date30/03/2031/03/2130/03/2318/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread



0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread



-3,91
-0,70
-458.86%
-6,43
-0,90
-614.33%
-3,92
-1,00
-292.3%
-2,07
-1,50
-37.87%
-2,12
-2,35
9.83%

-3,06


-3,19


-3,46


-3,59

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread















0,62
-2,70
122.85%

-3,06


-3,19


-3,46


-3,59

Net income
Million USD
Released
Forecast
Spread
-0,66


0,58
-0,70
182.26%
-7,54
-0,90
-738.26%
-4,01
-1,73
-131.75%
0,53
-2,23
123.59%
0,64
-2,48
125.76%

-3,06


-3,19


-3,46


-3,59

EPS
USD
Released
Forecast
Spread
-0,45


1,23
-0,15
920%
-1,37
-0,13
-953.85%
-0,52
-0,29
-79.31%
0,06
-0,26
123.08%
0,56
-0,10
660%

-0,12


-0,10


-0,11


-0,09

Announcement Date10/11/2230/03/2310/05/2310/08/2313/11/2318/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise